ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy. IL-13 is an immune regulatory cytokine and IL-13Ra2 is highly and specifically ...
Tags: Immunocellular, US Patent, Alpha 2 Protein
Clinical-stage company ImmunoCellular Therapeutics has named Andrew Gengos as the company's president, chief executive officer and board member. Gengos has served several companies and gained experience in areas such as corporate ...
Tags: ImmunoCellular, clinical, named, company's president